Lidsky and Allen posing together

Gastrointestinal Cancer

Duke Cancer Institute's Gastrointestinal Cancer disease group applies research findings to clinical practices to continually improve patient outcomes.

gift purple logo

Donate to Support Pancreatic and Gastrointestinal Cancer Research at Duke

We treat colorectal cancer (colon and rectal), esophageal cancer, stomach (gastric) cancer, anal cancer, liver cancer, pancreatic cancer, bile duct cancer (cholangiocarcinoma), gallbladder cancer, and neuroendocrine cancer. Our physicians specialize in the treatment of aggressive and complex GI cancers.

Patients with GI cancers benefit from our refined approaches to risk assessment, advances to improve responses to existing treatments, and the development of more effective treatments. The best approach depends on the tumor type, stage, and personal goals.

Contacts

Tonya Miltier

Administrative Director

919-660-4124

Emily Bolch

Assistant Research Practice Manager

919-668-6359
gift purple logo

Donate to Support Pancreatic and Gastrointestinal Cancer Research at Duke

This page was reviewed on 01/17/2024